LeonaBio, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$102.3M | -$100.9M | -$125.5M | -$104.0M | -$64.0M |
| Cash from operations | -$45.7M | -$97.2M | -$100.8M | -$72.5M | -$43.1M |
| Capital expenditure | — | $33,000 | $304,000 | $1.1M | $1.6M |
| Free cash flow | — | -$97.2M | -$101.1M | -$73.6M | -$44.7M |
| Total assets | $92.2M | $58.8M | $160.2M | $258.2M | $332.0M |
| Total liabilities | $64.4M | $13.9M | $30.1M | $23.0M | $10.9M |
Shares outstanding 9.4M · Free float 94.3%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.